James DeGregori, Paul Pharoah, Peter Sasieni, Charles Swanton
Cancer cell 2020 Oct 12Screening leads to meaningful reductions in deaths from cancers. However, reductions in all-cause mortality (ACM) are harder to demonstrate. Failure to demonstrate ACM benefit should not diminish advances in cancer screening. We consider how co-morbidities related to an aging and damaged soma can hinder achievement of ACM benefit. Crown Copyright © 2020. Published by Elsevier Inc. All rights reserved.
James DeGregori, Paul Pharoah, Peter Sasieni, Charles Swanton. Cancer Screening, Surrogates of Survival, and the Soma. Cancer cell. 2020 Oct 12;38(4):433-437
PMID: 32946774
View Full Text